Tanke Biosciences Free Cash Flow (FCF) History (TNBI)

Tanke Biosciences reported −$2.0M in free cash flow for fiscal 2012, a decrease of $5.0M from the previous fiscal year, with a free cash flow margin of −7.14%.

View full Tanke Biosciences company overview

Tanke Biosciences free cash flow by year

Tanke Biosciences annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20122012-12-31−$2.0M−$5.0M−7.14%
20112011-12-31$3.0M−$1.4M−31.49%+12.39%
20102010-12-31$4.3M+21.44%

Tanke Biosciences free cash flow growth trends

Tanke Biosciences's latest reported quarter, Q3 2013, generated $538,076 in free cash flow, a decrease of 52.83% year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Tanke Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about TNBI yet. Start the conversation.

Write the first post